SCHEMBL13743019

SCHEMBL13743019

CC(C)C1CC(O)CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29054509 0.83
SCHEMBL14554722 0.80 THRB (0.38)
SCHEMBL14707865 0.80 THRB (0.38)
SCHEMBL11946929 0.80 THRB (0.38)
SCHEMBL14554567 0.80 THRB (0.38)
SCHEMBL14707864 0.80 THRB (0.38)
SCHEMBL11953949 0.80 THRB (0.38)
SCHEMBL11953952 0.80 THRB (0.38)
SCHEMBL14555942 0.80 THRB (0.38)
SCHEMBL11946967 0.80 THRB (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230135152-A1 PIKFYVE KINASE INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-04 US disclosed
WO-2021163727-A1 PIKFYVE KINASE INHIBITORS AcuraStem Incorporated (US) 2021-08-19 WO disclosed
US-20170145046-A1 6-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY CLINIGEN GROUP PLC (GB) 2017-05-25 US disclosed
US-20140031539-A1 6-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY Biocodex, Inc (US) 2014-01-30 US disclosed
US-20090209535-A1 6-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY TOPOTARGET A/S (DK) 2009-08-20 US disclosed